FDA approves first flu vaccine that can be self-administered at home
The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a ...
FDA approves first self-administered flu vaccine spray
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
STAT8h
FDA approves first at-home flu vaccine in U.S., a nasal spray
FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...
HealthDay on MSN5h
FDA Approves First Flu Vaccine You Give Yourself at Home
The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug ...
FDA approves first self-administered flu vaccine
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...
MedPage Today10h
FDA OKs First Flu Vaccine for At-Home Use
The FDA approved FluMist for self- or caregiver-administration, making it the first influenza vaccine that does not need to ...
US FDA approves AstraZeneca's flu vaccine for self-administration
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
WBIW11h
FDA approves first nasal spray influenza vaccine for self or caregiver administration
INDIANA- Today, the U.S. Food and Drug Administration approved FluMist for self– or caregiver-administration. FluMist is ...
FDA approves first nasal spray flu vaccine for use at home
The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a ...
US FDA approves AstraZeneca's self-administered nasal spray flu vaccine
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's influenza nasal spray vaccine for ...
Monthly Prescribing Reference9h
FDA Approves Self-Administration of Influenza Vaccine FluMist
FluMist is a nasally-administered influenza vaccine that is indicated for active immunization to prevent influenza disease in individuals 2 to 49 years of age.